Centenarian Sequencing Contest Begins

The first company to attempt to cheaply sequence the genomes of 100 people aged over 100 announced its intention to compete for the 2013 X prize.

Written byEdyta Zielinska
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Ion Torrent, a high-tech sequencing company, announced on Monday (July 23) that it will try to sequence 100 genomes of centenarians for $1,000 each, in 30 days, making it the first company to enter next year’s X Prize competition, which promises $10 million to the winning team.

There is still plenty of time for other contestants to throw their hats in. The contest doesn’t begin until September 2013, and entries are permitted up until next May. The criteria for winning, however, are quite stiff, requiring that contestants sequence genomes at less than $1,000 a pop, with at least 98 percent completion and less than one error per million base pairs, reported Nature. As the contestants look for gene variants that could be involved in longevity, they also must be able to report which variants came from which chromosomal.

Since several “next-next gen” sequencing companies, or companies that have developed new ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies